Cancer patients with rare deadly brain infection treated successfully with off-the-shelf adoptive T-cell therapy
(University of Texas M. D. Anderson Cancer Center) An emerging treatment known as adoptive T-cell therapy has proven effective in a Phase II clinical trial for treating progressive multifocal leukoencephalopathy (PML), a rare and often fatal brain infection sometimes observed in patients with cancer and other diseases in which the immune system is compromised.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Clinical Trials | Neurology | Texas University